Gloria Berinyuy Tata is addressing the need for improved screening procedures for the early detection of Streptococcus agalactiae, a leading cause of neonatal and maternal sepsis. Her proposed solution involves developing a novel molecular diagnostic tool based on the LAMP-CRISPR-Cas 12 technology, aiming to provide an accurate, affordable, and simple-to-use method for early detection.

Further Activities to have a look at